跳至主要内容
临床试验/NCT05981495
NCT05981495尚未招募不适用

Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease

NanoPin Technologies, Inc.0 个研究点目标入组 460 人开始时间: 2023年8月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
460
主要终点
NanoDetect-TB result compared to sputum culture

研究概览

简要总结

The goal of this observational study is investigate the accuracy of the NanoDetect-TB kit in diagnosing tuberculosis (TB) using frozen serum and plasma samples collected from individuals suspected to have TB disease.

The main question[s] it aims to answer are:

  • How does this investigational device compare to the gold standard for TB diagnosis of sputum culture?
  • How does it compare to Acid-Fast Bacteria (AFB) smear microscopy and FDA-approved NAAT TB diagnostic assays?

Participants will be asked to have blood drawn and provide demographic and medical data for this study in a single visit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Children and adults aged two years or older (including older adults that are 65+)
  • Ability and willingness to provide informed consent/assent/permission, and a parent/legal guardian willing to give consent on the child's behalf for study participants aged 2-17 years
  • Ability and willingness to perform study procedures, or parent/legal guardian to provide consent for a child to undergo study procedures on their behalf (when applicable)
  • Clinical signs and symptoms typically associated with active TB disease including, but not limited to:
  • Cough for > two (2) weeks Lethargy, weakness, malaise Reduced playfulness (pediatric population) Weight loss or loss of appetite Failure to thrive (pediatric population) Fever Chest pain Night sweats
  • Physician (or healthcare provider) suspicion of TB disease

排除标准

  • Pregnancy (based on participant-provided information)
  • Any physical or mental health condition for which participation in the study, as judged by the investigator, could compromise the well-being of the subject and/or prevent, limit, or confound protocol-specified procedures
  • Critical illness needing immediate medical care
  • Receipt of treatment for active TB or LTBI in the past 24 months

结局指标

主要结局

NanoDetect-TB result compared to sputum culture

时间窗: Single visit for patient for blood draw.

The investigational device results will be compared to the primary reference of sputum culture for determining relative sensitivity and specificity.

次要结局

  • NanoDetect-TB result compared to AFB Smear and NAAT(Single visit for patient for blood draw.)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验